✦ LIBER ✦

Erythropoietin biosimilars currently available in hematology-oncology

✍ Scribed by Didier Kamioner

Book ID: 113084817
Publisher: Springer-Verlag
Year: 2012
Tongue: English
Weight: 139 KB
Volume: 7
Category: Article
ISSN: 1776-2596
DOI: 10.1007/s11523-011-0191-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Presently available biosimilars in hemat

Presently available biosimilars in hematology-oncology: G-CSF

✍ Pere Gascon 📂 Article 📅 2012 🏛 Springer-Verlag 🌐 English ⚖ 102 KB

Presently available biosimilars in hemat

Presently available biosimilars in hematology-oncology — Part II: G-CSF

✍ P. Gascon 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 French ⚖ 89 KB

Biosimilars and their use in hematology

✍ Cornelius F. Waller 📂 Article 📅 2012 🏛 Frontline Medical Communications, Inc. 🌐 English ⚖ 702 KB

Current awareness in hematological oncol

Current awareness in hematological oncology

📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 919 KB

Multiple myeloma and chronic lymphocytic leukemia -Parallels and contrasts (Review)

Current awareness in hematological oncol

Current awareness in hematological oncology

📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 835 KB

Management of acute myeloid leukaemia (Review) Cho a R// Univ Coll & Middlesex Sch Med, Dept Haematol,.Endon,E, and B n t J H o q M e f l 9 9 2 48 (7) 363 Prognostic factors and monitoring of multiple myeloma (Review)

Current awareness in hematological oncol

Current awareness in hematological oncology

📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 1014 KB